Eris Lifesciences Limited (ERIS.NS)
INR 1401.3
(0.86%)
INR 1401.3
(0.86%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 27.81 Billion INR | 217.24% |
| 2022 | 8.76 Billion INR | 938.67% |
| 2021 | 844.07 Million INR | 1145.49% |
| 2020 | 67.77 Million INR | -44.19% |
| 2019 | 121.43 Million INR | -93.12% |
| 2018 | 1.76 Billion INR | -53.18% |
| 2017 | 3.76 Billion INR | 4756.28% |
| 2016 | 77.59 Million INR | 1451.8% |
| 2015 | 5 Million INR | -85.1% |
| 2014 | 33.56 Million INR | -57.71% |
| 2013 | 79.36 Million INR | 17.0% |
| 2012 | 67.83 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 26.95 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 27.81 Billion INR | 217.24% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 27.81 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 8.29 Billion INR | 0.0% |
| 2022 Q4 | 8.76 Billion INR | 0.0% |
| 2022 Q2 | 2.61 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 8.76 Billion INR | 938.67% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 844.07 Million INR | 1145.49% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 844.07 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 443.42 Million INR | 0.0% |
| 2020 FY | 67.77 Million INR | -44.19% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 67.77 Million INR | 0.0% |
| 2020 Q2 | 88.21 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 121.43 Million INR | -93.12% |
| 2019 Q4 | 121.43 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 169.27 Million INR | 0.0% |
| 2018 Q2 | 1.74 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 1.76 Billion INR | 0.0% |
| 2018 FY | 1.76 Billion INR | -53.18% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q2 | 4.24 Million INR | 0.0% |
| 2017 Q4 | 3.76 Billion INR | 0.0% |
| 2017 FY | 3.76 Billion INR | 4756.28% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 FY | 77.59 Million INR | 1451.8% |
| 2016 Q4 | 77.59 Million INR | 0.0% |
| 2016 Q2 | 44.33 Million INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 5 Million INR | -85.1% |
| 2014 FY | 33.56 Million INR | -57.71% |
| 2013 FY | 79.36 Million INR | 17.0% |
| 2012 FY | 67.83 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -1844.24% |
| Ind-Swift Limited | 10.13 Billion INR | -174.288% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -735.657% |
| Sakar Healthcare Limited | 793.51 Million INR | -3404.994% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 58.161% |
| Innova Captab Limited | 2.45 Billion INR | -1034.73% |
| Divi's Laboratories Limited | 30 Million INR | -92608.967% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -60386.038% |
| Morepen Laboratories Limited | 289.99 Million INR | -9490.847% |
| Mankind Pharma Limited | 2.07 Billion INR | -1242.49% |
| Sequent Scientific Limited | 4.87 Billion INR | -470.291% |
| Wanbury Limited | 1.16 Billion INR | -2287.671% |
| Laurus Labs Limited | 25.77 Billion INR | -7.91% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -337.626% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -16119.203% |
| Alembic Limited | 91.5 Million INR | -30296.383% |
| Hikal Limited | 8.17 Billion INR | -240.183% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -441.989% |
| Neuland Laboratories Limited | 953.89 Million INR | -2815.694% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -636.448% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -125.949% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -8389.832% |
| Themis Medicare Limited | 957.92 Million INR | -2803.44% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -245.843% |
| Lupin Limited | 29.21 Billion INR | 4.809% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -160825.129% |
| Wockhardt Limited | 23.56 Billion INR | -18.05% |
| Vaishali Pharma Limited | 134.91 Million INR | -20514.514% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -875.029% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -31006.912% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 24.092% |
| FDC Limited | 205.18 Million INR | -13454.933% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -38.925% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -8688.552% |
| Venus Remedies Limited | 413.3 Million INR | -6629.419% |
| ZIM Laboratories Limited | 1.08 Billion INR | -2455.74% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -2685.723% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -141081.168% |
| Shilpa Medicare Limited | 9.37 Billion INR | -196.704% |
| Albert David Limited | 33.24 Million INR | -83567.321% |
| Ajanta Pharma Limited | 352.8 Million INR | -7783.416% |
| Hester Biosciences Limited | 2.44 Billion INR | -1038.101% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -4179.112% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -174.965% |
| Gufic Biosciences Limited | 3.32 Billion INR | -735.427% |
| Windlas Biotech Limited | 36.41 Million INR | -76287.503% |
| Procter & Gamble Health Limited | 95.6 Million INR | -28992.772% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -8771.019% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -2723.838% |
| Granules India Limited | 13.15 Billion INR | -111.493% |
| Aarti Drugs Limited | 5.64 Billion INR | -392.897% |
| Bal Pharma Limited | 1.39 Billion INR | -1891.623% |
| Alkem Laboratories Limited | 14.18 Billion INR | -96.084% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 15.041% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -260611.38% |
| Medicamen Biotech Limited | 308.17 Million INR | -8925.054% |
| Unichem Laboratories Limited | 2.47 Billion INR | -1023.681% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -11303.644% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -633590.818% |
| Valiant Laboratories Limited | 767.08 Million INR | -3525.768% |
| Orchid Pharma Limited | 1.35 Billion INR | -1957.447% |
| Medico Remedies Limited | 80.5 Million INR | -34448.209% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -16632.86% |
| Ipca Laboratories Limited | 14.38 Billion INR | -93.364% |
| Brooks Laboratories Limited | 56.41 Million INR | -49196.673% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -3736.942% |
| Piramal Enterprises Limited | 535.85 Billion INR | 94.81% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 30.849% |
| NATCO Pharma Limited | 3.71 Billion INR | -649.264% |
| Suven Life Sciences Limited | 7.09 Million INR | -391793.617% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1337.872% |
| Strides Pharma Science Limited | 25.16 Billion INR | -10.505% |
| Indoco Remedies Limited | 6.71 Billion INR | -313.904% |
| Alpa Laboratories Limited | 52.46 Million INR | -52911.894% |
| Lasa Supergenerics Limited | 220.76 Million INR | -12498.495% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -4448.273% |